MedPath

Miglitol

Generic Name
Miglitol
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C8H17NO5
CAS Number
72432-03-2
Unique Ingredient Identifier
0V5436JAQW
Background

Miglitol inhibits the breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body.

Miglitol should be taken at the start of a meal for maximal effect and the effect will depend on the amount of poly and oligosaccharides in the diet. Miglitol inhibits alpha-glucosidase, making less sugars available for digestion and reducing postprandial hyperglycemia.

Unlike other drugs of the same class, miglitol is not metabolized and the unmetabolized drug is excreted by the kidneys.

Indication

For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.

Associated Conditions
Type 2 Diabetes Mellitus
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath